Grid Exponential

SphereBio, established in 2023, specializes in developing biotechnology platforms that facilitate the delivery of molecules to cells, thereby training them to respond to specific health issues. The company leverages its platforms to provide pharmaceutical and veterinary businesses with innovative methods to enhance vaccines and therapeutics, tailored to combat diseases like cancer.

MicroIN is a biotechnology company that specializes in enhancing the stability and effectiveness of biological products, particularly in the agro-environmental sector. It achieves this by developing customized encapsulation protocols for microorganisms, improving their viability and optimizing bioinput formulations.

Polymera leverages the adaptive mechanisms of an extremophile antarctic bacterium to develop naturally biodegradable biopolymers.

MIGMA uses Artificial Intelligence to accelerate the discovery of new synergistic combinations of antioxidants.

BioBlends develops biopreservatives for the food industry to extend the shelf life of food products.

Apasomics is a biotechnology company specializing in bone-targeted drug delivery systems. It uses apasome-based nanocarriers to deliver bisphosphonates directly to bones, enhancing the efficacy of treatments for osteoporosis and other skeletal disorders while minimizing side effects. By combining nanotechnology and precision medicine, Apasomics aims to improve therapeutic outcomes and patient quality of life, and explore new frontiers in regenerative medicine.

GlycoX is a biotechnology company specializing in innovative diabetes management solutions. It develops an oral solution aimed at controlling blood glucose levels, empowering individuals with diabetes to improve their health and quality of life. The company combines natural elements with advanced technology to revolutionize diabetes treatment.

Nanoingreen is a company focused on transforming plant-based products into functional foods through innovative formulations. Utilizing precision fermentation processes, it develops next-generation nutritious foods designed to provide specific health benefits and prevent potential future health issues. By synthesizing functional ingredients, Nanoingreen enables its clients to enhance their plant-based offerings with diverse flavors and textures, thereby contributing to the advancement of nutritious food solutions in the market.

APEXzymes develops high-performance microbial technologies for the industrial production of biofertilizers and enzymes.

Dogma BioTech is a biotechnology firm that develops protein-based therapeutics.

AlgaLife is a biotechnology company that focuses on improving microalgae cultivation processes, enabling 95% cheaper production costs while maintaining high yields. The company's core product is a microalgae consortium designed to enhance aquaculture efficiency and sustainability. This consortium improves gut health and immunological activity in farmed aquatic animals, reducing mortality rates and enabling the aquaculture industry to meet sustainability challenges more effectively.

Ocular Bio Design is a tissue engineering company for the regeneration of visual function.

Smart delivery biocapsules that enhance crop production.

Aquit is a biotechnology company specializing in the development of preventive treatments for fish infections. Their innovative solutions aim to replace antibiotics, thereby enhancing fish immunity, improving survival rates, and promoting sustainable aquaculture practices.

Gisens Biotech is a biotechnology firm specializing in bioelectronics and nanotechnology. The company is recognized for its innovative approach to problem-solving and employs advanced technology to enhance its offerings. One of its flagship products is the Nano-Lab, a portable diagnostic device designed to measure and control various biomarkers. This device can accurately analyze concentrations of renal biomarkers such as urea, creatinine, and potassium from a single drop of blood, urine, or saliva. By providing real-time measurements through a user-friendly application, the Nano-Lab enables efficient health monitoring, potentially transforming the way biomarker assessments are conducted and interpreted.

Eywa is a biotechnology company specializing in the development of innovative production methods for psychedelic medicines. It focuses on designing efficient processes and products to enhance the adoption of these treatments, leveraging biosynthesis to create patient-centered therapies aimed at improving mental health outcomes.

Fungi Life is a biotechnology company focused on producing biosurfactants through advanced fungal technology. The firm aims to replace synthetic surfactants with environmentally friendly alternatives derived from fungi. By developing surfactants and enzymes, Fungi Life provides sustainable solutions for various industries, including oil and gas, cleaning, cosmetics, agriculture, and personal care. These innovations enable companies to substitute petroleum-based ingredients with biodegradable options, thereby reducing their environmental impact and promoting sustainability.

Updairy is a company that produces food ingredients, specifically animal-free dairy proteins. It uses microorganisms to create these proteins, mimicking the taste and nutrition of traditional dairy products but with significantly reduced greenhouse gas emissions. This allows customers to develop new dairy products with a lower environmental impact than traditional dairy farming.

Kresko RNAtech is a biotechnology company focused on the development and production of nutraceuticals. The company specializes in identifying bioactive ribonucleic acid (RNA) from natural sources, utilizing advanced techniques such as machine learning and bioinformatics. By uncovering RNAs that may offer health benefits, Kresko RNAtech aims to enhance human well-being and help individuals manage stressful and changing conditions through innovative RNA technologies.

Nanotransfer specializes in developing innovative delivery systems utilizing inorganic nanoparticles for gene therapy applications. Their technology allows clients to create custom genetic material that can be easily integrated with the Nanotransfer systems, enhancing versatility through the ability to transport various nucleic acids. The delivery systems are designed to be non-immunogenic and biocompatible, ensuring that any patient can receive treatment without adverse reactions. They offer high specificity for targeting certain cell types and demonstrate significant cellular internalization. Furthermore, the production process is scalable and cost-effective, facilitating broader access to gene therapies. Nanotransfer's systems can escape endosomal entrapment and resist enzymatic degradation, enhancing their efficacy. By decoupling the synthesis of the delivery system from that of the therapeutic gene, the company aims to foster the development of diverse therapies that positively impact patient health.

Cryosmetics is dedicated to advancing the future of cosmetics through the development of natural skincare products. The company focuses on enhancing the diversity of the skin microbiome, utilizing a blend of technology, science, and biology in its approach. By employing natural raw materials and ensuring that its products are free from preservatives and synthetic chemicals, Cryosmetics aims to improve the overall well-being of its customers.

Fecundis is a company based in Rosario, Argentina, focused on advancing reproductive biology. It develops innovative solutions aimed at improving sperm competence and enhancing the success rates of assisted reproductive technologies. By utilizing precise technology grounded in scientific research, Fecundis enhances sperm functionality, leading to the generation of more viable embryos. The company’s tools are designed to optimize fertility treatments, ultimately enabling patients to achieve successful pregnancies.

CASPR Biotech, founded in 2018 and located in San Francisco, California, specializes in the development of a CRISPR-based platform for diagnosing antimicrobial resistances (AMR) and infectious diseases. The company creates portable diagnostic kits that enable the detection of specific DNA and RNA sequences, as well as signature amino acid sequences associated with infectious diseases and genetic mutations. These kits aim to provide healthcare professionals with a simple, rapid, and cost-effective solution for molecular detection, enhancing the accuracy and efficiency of clinical diagnostics.

Feedvax is an Argentine company founded in 2018 that specializes in developing oral vaccines for farmed fish, aiming to enhance animal production sustainably. The company has created a platform that delivers in-feed vaccines, beginning with a product targeting streptococcosis in tilapia, a widely farmed fish species. Feedvax's innovative approach allows for easy administration of vaccines through feed, providing an effective and environmentally safe alternative to antibiotics. This method not only protects fish from disease but also minimizes stress and potential contamination, offering a practical solution for fish producers seeking greater efficiency in aquaculture.

AlgaeBio+ is a company based in Argentina that specializes in the production of natural astaxanthin, an antioxidant derived from the microalga Haematococcus pluvialis. This product is known for its immunoregulatory, anti-inflammatory, and photo-protective properties, making it beneficial in the treatment of various health conditions, including chronic diseases and cancer. AlgaeBio+ serves multiple industries, including pharmaceuticals, nutraceuticals, functional foods, and cosmetics, offering a natural alternative to artificial pigments. The cultivation process begins in laboratory conditions and progresses through production in photobioreactors, ensuring high-quality output. By emphasizing the health benefits of astaxanthin for joints, muscles, vision, and heart health, AlgaeBio+ aims to enhance patient treatment options while promoting preventive care and anti-aging solutions.

APLIFE BIOTECH is an Argentine biotech startup founded in 2018, based in Buenos Aires. The company focuses on developing innovative technologies for the high-throughput discovery of novel aptamers, which are essential for biosensors. APLIFE BIOTECH's platform specializes in manufacturing synthetic DNA-derived molecules and constructing large combinatorial libraries that facilitate the mass screening of significant biological molecules. This advanced biosensor technology aims to tackle global challenges in medical diagnostics by enabling the creation of novel aptamers for various applications, including proteomic diagnostic assays and therapeutic uses.